575659-U
HybridSPE®-PLus 96-Well solid phase extraction (SPE) Plate
Volume 2 mL, bed wt., 50 mg, pk of 1 ea
Sinônimo(s):
HybridSPE®-PLus
About This Item
Produtos recomendados
Nome do produto
HybridSPE®-PLus 96-Well Plate, volume 2 mL, pk of 1 ea
descrição
96-well Plate
Nível de qualidade
linha de produto
HybridSPE®
composição
bed wt., 50 mg
embalagem
pk of 1 ea
técnica(s)
solid phase extraction (SPE): suitable
volume
2 mL
Grupo ativo da matriz
zirconia-based phase
Procurando produtos similares? Visita Guia de comparação de produtos
Categorias relacionadas
Descrição geral
Our HybridSPE-PLus products offer the same time-proven chemistry of our traditional HybridSPE-Phospholipid products coupled with manufacturing enhancements that stem from years of production experience. These manufacturing enhancements have allowed us to increase flow consistency and reduce sample hold up volumes, further improving analyte recoveries and assay reproducibility. We invite customers to take advantage of the newest technology; HybridSPE-PLus.
Características e benefícios
- Simple 2-3 step standard methodology analogous to traditional protein precipitation provides simultaneous removal of both proteins and phospholipids
- Unique Lewis acid/base retention mechanism effectively removes phospholipids from both hydrophilic and hydrophobic analytes of interest (unlike competitive chemistries) eliminating phospholipid-induced ion suppression
- Highly reproducible, consistent product performance
- Provides cleaner samples for longer column life and less instrument downtime
- Available in 96-well and 1 mL cartridge dimensions
Informações legais
Código de classe de armazenamento
11 - Combustible Solids
Classe de risco de água (WGK)
WGK 3
Ponto de fulgor (°F)
Not applicable
Ponto de fulgor (°C)
Not applicable
Escolha uma das versões mais recentes:
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Os clientes também visualizaram
Artigos
Using HybridSPE-Phospholipid, Ascentis Express, and Other LC-MS Workflow Components
This article highlights the impact that sample matrix effects can have on LC/MS response and discusses two novel approaches to reduce it.
Protocolos
Immunoassay-based methods for digitoxin or digoxin exist, but are time consuming, labor intensive, and not selective due to similarities in their chemical structures.
LC/MS/MS Analysis of Interacting Cardiac Drugs Digoxin, Quinidine, Amiodarone and Verapamil on Titan™ C18
Conteúdo relacionado
Small molecules are ions and compounds of molecular weight typically less than 900 daltons. These compounds can be effectively separated and analyzed by HPLC, UHPLC and LC-MS using mainly silica particles or monolithic stationary phases with a broad range of column chemistries (modifications).
Solid phase extraction purifies samples for chromatographic analysis, improving data quality and protecting analytical columns.
Chromatograms
application for HPLC, application for SPENossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica